Developing Sepsis Quality Indicators for Sub-Saharan Africa
Part of Infections clinical trials.
This study aims to develop quality indicators for early sepsis care in Sub-Saharan Africa using a structured expert consensus process (modified Delphi). Healthcare professionals with experience in sepsis care or research in low- and middle-income countries are invited to participate in online survey rounds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have professional experience with sepsis care or sepsis research in low- or middle-income countries, especially Sub-Saharan Africa.
- You are a physician, nurse, researcher, or other healthcare professional involved in early acute care or quality assurance.
- You are at least 18 years old.
- You are willing to participate in online surveys (Delphi rounds).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an anonymous online survey to understand how healthcare workers in seven African countries recognize and manage sepsis. Your answers could help improve sepsis care across the continent.
This study gathers expert opinions from critical care doctors and specialists around the world who use bedside ultrasound (a portable imaging tool) to diagnose and categorize septic shock (a life-threatening infection condition). The goal is to develop standardized approaches to identifying different types of septic shock using ultrasound.
This study tests a new, timely approach to managing sepsis (a severe infection that can harm the body). It aims to improve care in the Emergency Department and Intensive Care Unit, which could help patients recover faster.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This trial is testing whether certain biomarkers (substances in your body) can help diagnose sepsis faster. Sepsis is a serious condition where your body has a severe response to an infection. The study will look at blood or other samples to see if these markers can quickly tell if you have sepsis, which could lead to faster treatment.
This trial looks at a new program to improve how doctors and nurses treat sepsis (a severe infection that can cause organ failure) in the emergency department. It aims to see if the program helps start the right treatments faster.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.